Wockhardt Limited's Zaynich antibiotic shows over 97% efficacy against carbapenem-resistant bacteria, impacting global ...

Mumbai: Wockhardt has announced that Zaynich (Zidebactam/Cefepime, WCK 5222) demonstrated over 97 percent clinical efficacy ...

Shares of Wockhardt were in high demand on Monday after the company said that its drug Zaynich has achieved over 97 per cent ...

Indian benchmark indices opened in the red, reflecting a negative start to the trading week. However, one stock bucked the ...